Evidence map›Paper›PMID 39211331›Full record

ArticleNAR genomics and bioinformatics2024

SpikeFlow: automated and flexible analysis of ChIP-Seq data with spike-in control.

Davide Bressan, Daniel Fernández-Pérez, Alessandro Romanel, Fulvio Chiacchiera

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Davide BressanDepartment of Cellular, Computational, and Integrative Biology, University of Trento, Via Sommarive 9, 38123 Povo - Trento, Italy.ORCID https://orcid.org/0000-0003-4757-2535
Daniel Fernández-PérezQuantitative Stem Cell Dynamics Laboratory, IRB Barcelona, Carrer de Baldiri Reixac 10, 08028 Barcelona, Spain.ORCID https://orcid.org/0000-0002-1679-6555
Alessandro RomanelDepartment of Cellular, Computational, and Integrative Biology, University of Trento, Via Sommarive 9, 38123 Povo - Trento, Italy.ORCID https://orcid.org/0000-0003-4855-8620
Fulvio ChiacchieraDepartment of Cellular, Computational, and Integrative Biology, University of Trento, Via Sommarive 9, 38123 Povo - Trento, Italy.ORCID https://orcid.org/0000-0003-3830-2090

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ChIP with reference exogenous genome (ChIP-Rx) is widely used to study histone modification changes across different biological conditions. A key step in the bioinformatics analysis of this data is calculating the normalization factors, which vary from the standard ChIP-seq pipelines. Choosing and applying the appropriate normalization method is crucial for interpreting the biological results. However, a comprehensive pipeline for complete ChIP-Rx data analysis is lacking. To address these challenges, we introduce SpikeFlow, an integrated Snakemake workflow that combines features from various existing tools to streamline ChIP-Rx data processing and enhance usability. SpikeFlow automates spike-in data scaling and provides multiple normalization options. It also performs peak calling and differential analysis with distinct modalities, enabling the detection of enrichment regions for histone modifications and transcription factor binding. Our workflow runs in-depth quality control at all the processing steps and generates an analysis report with tables and graphs to facilitate results interpretation. We validated the pipeline by performing a comparative analysis with DiffBind and SpikChIP, demonstrating robust performances in various biological models. By combining diverse functionalities into a single platform, SpikeFlow aims to simplify ChIP-Rx data analysis for the research community.

Identifiers

PMID39211331
PMCPMC11358820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.